Abstract
The drugs currently used to treat the negative symptoms of schizophrenia are inadequate, and the methods used to evaluate their efficacy impractical and conceptually flawed. I will attempt to clarify these issues, but they are complex, and the solutions I suggest will not be completely satisfactory.
Publisher
Royal College of Psychiatrists
Subject
Psychiatry and Mental health
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献